SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-007912
Filing Date
2021-04-12
Accepted
2021-04-12 16:39:26
Documents
1
Period of Report
2021-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3971
  Complete submission text file 0001567619-21-007912.txt   5629
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address
McLaughlin Gerald W. (Reporting) CIK: 0001495412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 21821130